Altimmune Inc

General ticker "ALT" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $623.6M

Altimmune Inc does not follow the US Stock Market performance with the rate: -12.7%.

Estimated limits based on current volatility of 3.8%: low 7.78$, high 8.40$

Factors to consider:

  • Price in estimated range
  • Earnings for 9 months up through Q3 are close to our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2023-12-31 to 2025-12-30

  • 2023-12-31 to 2024-12-30 estimated range: [5.70$, 14.67$]
  • 2024-12-30 to 2025-12-30 estimated range: [4.32$, 11.50$]

Financial Metrics affecting the ALT estimates:

  • Negative: Non-GAAP EPS, $ of -1.65 <= 0.10
  • Negative: Operating profit margin, % of -99.56 <= 1.03
  • Negative: Operating cash flow per share per price, % of -18.62 <= 2.35
  • Negative: negative Net income
  • Negative: Industry earnings per price (median), % of -26.04 <= 1.31

Similar symbols

Short-term ALT quotes

Long-term ALT plot with estimates

Financial data

YTD 2021-12-31 2022-12-31 2023-12-31
Operating Revenue $4.41MM $0.00MM $0.43MM
Operating Expenses $101.32MM $87.74MM $96.36MM
Operating Income $-96.91MM $-87.74MM $-95.93MM
Non-Operating Income $-0.18MM $2.83MM $7.48MM
Interest Expense $0.01MM $0.01MM $0.04MM
R&D Expense $74.54MM $70.54MM $65.80MM
Income(Loss) $-97.09MM $-84.91MM $-88.45MM
Taxes $0.00MM $-0.20MM $0.00MM
Profit(Loss) $-97.09MM $-84.71MM $-88.45MM
Stockholders Equity $199.13MM $185.29MM $194.10MM
Assets $218.86MM $206.93MM $210.64MM
Operating Cash Flow $-78.24MM $-62.59MM $-75.81MM
Capital expenditure $12.31MM $0.13MM $0.05MM
Investing Cash Flow $87.52MM $-73.40MM $13.73MM
Financing Cash Flow $65.10MM $56.78MM $86.11MM
Earnings Per Share* $-2.33 $-1.81 $-1.66

* EPS are Split Adjusted, recent splits may be reflected with a delay.